GLAXOSMITHKLINE FINANCE PLC
Get an alert when GLAXOSMITHKLINE FINANCE PLC files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-05-13 (in 1y)
Last made up 2026-04-29
Watchouts
None on the register
Cash
£2B
+25.2% vs 2023
Net assets
£60B
+1% vs 2023
Employees
—
Average over period
Profit before tax
£3B
+57% vs 2023
Name history
Renamed 3 times since incorporation
- GLAXOSMITHKLINE FINANCE PLC 2001-10-01 → present
- SMITHKLINE BEECHAM FINANCE P.L.C. 1989-10-03 → 2001-10-01
- BEECHAM FINANCE P L C 1980-12-31 → 1989-10-03
- BEECHAM FOODS LIMITED 1929-10-02 → 1980-12-31
Net assets
2-year trend · vs Financials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | £198,480,000 | £267,051,000 | |
| Profit before tax | £1,698,480,000 | £2,667,051,000 | |
| Net profit | £1,651,652,000 | £2,599,793,000 | |
| Cash | £1,849,932,000 | £2,316,344,000 | |
| Total assets less current liabilities | £63,540,420,000 | £64,141,422,000 | |
| Net assets | £59,741,600,000 | £60,341,393,000 | |
| Equity | £59,741,600,000 | £60,341,393,000 | |
| Average employees | 0 | — | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | 0.3% | 0.4% | |
| Gearing (liabilities / total assets) | 60.6% | 60.9% | |
| Current ratio | 0.11x | 0.09x | |
| Interest cover | 0.05x | 0.06x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Having assessed the principal risks of the Company and other matters, the Directors are of the opinion that the current level of activity remains sustainable. The Directors in their considerations have included the accessibility of additional capital and the potential risk to liquidity. The Directors have considered the Company's ability to continue as a going concern for a minimum of twelve months from the date of signing of these financial statements. The Directors have taken into account that as part of the Group, the Company has the support from the Group through the access to the Group cash pooling mechanism and can take actions to ensure business continuity through operational channels, as well as the ability to manage variable costs. On the basis of those considerations, the Directors believe that it remains appropriate to adopt the going concern basis of accounting in preparing the financial statements.”
Group structure
- GLAXOSMITHKLINE FINANCE PLC · parent
- 14245563 CANADA INC. 100%
- 14934792 Canada Inc. 100%
- Action Potential Venture Capital Limited 100%
- Bellus Health Inc 71.03%
- GlaxoSmithKline Finance plc
Significant events
- “IFRS 18 Presentation and disclosure in financial statements: The standard was issued by the IASB on 9 April 2024 and introduces new presentation and disclosure requirements. The Company is assessing the impact of adopting the new requirements introduced by IFRS 18, and will adopt the standard for the reporting period ending 31 December 2027, subject to endorsement in the UK.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 16 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| WHYTE, Victoria Anne | Secretary | 2002-01-18 | — | British |
| WALKER, Adam | Director | 2019-02-11 | Nov 1967 | British |
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Director | 2001-02-28 | — | — |
| GLAXO GROUP LIMITED | Corporate Director | 2001-02-28 | — | — |
| THE WELLCOME FOUNDATION LIMITED | Corporate Director | 2007-03-05 | — | — |
Show 16 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BALFOUR, Ian Main Ferguson | Secretary | — | 1994-01-01 |
| BICKNELL, Simon | Secretary | 2013-07-30 | 2014-03-10 |
| BRYANT, Karina Jane | Secretary | 1999-12-20 | 2002-01-18 |
| COOMBER, Caroline Daphne | Secretary | 1998-09-04 | 1999-12-20 |
| DILLON, Alison Marie | Secretary | — | 1998-09-04 |
| HORLER, Alison Marie | Secretary | 1994-01-01 | 1994-01-01 |
| WILBRAHAM, Simon Nicholas | Secretary | 1998-09-04 | 2001-02-28 |
| BLACKBURN, Paul Frederick | Director | 1999-01-01 | 2001-03-01 |
| BONFIELD, Andrew Robert John | Director | 1994-04-11 | 2000-12-27 |
| COLLUM, Hugh Robert | Director | — | 1998-12-31 |
| CROMPTON, Stephen Thomas | Director | — | 2001-03-01 |
| DEE, Nicholas Charles | Director | — | 2001-03-01 |
| DINGEMANS, Simon Paul | Director | 2011-04-01 | 2019-05-01 |
| HESLOP, Julian Spenser | Director | 2009-09-09 | 2011-03-31 |
| HOUSE, Philip Glyn | Director | — | 1994-04-11 |
| VICENTINI, Simone | Director | 2011-12-01 | 2019-02-11 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Glaxosmithkline Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 216 total filings
Material constitutional events — rename, articles re-file, resolution
- 2026-02-15 CC04 Statement of companys objects
- 2026-01-28 RESOLUTIONS Resolution
- 2026-01-28 MA Memorandum articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-02-15 | CC04 | change-of-constitution | Statement of companys objects | |
| 2026-01-28 | RESOLUTIONS | resolution | Resolution | |
| 2026-01-28 | MA | incorporation | Memorandum articles | |
| 2025-09-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-09 | AA | accounts | Accounts with accounts type full | |
| 2024-11-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-23 | CH03 | officers | Change person secretary company with change date | |
| 2024-09-17 | CH01 | officers | Change person director company with change date | |
| 2024-09-11 | CH02 | officers | Change corporate director company with change date | |
| 2024-09-11 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-09-11 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-07-18 | AD02 | address | Change sail address company with new address | |
| 2024-07-03 | AA | accounts | Accounts with accounts type full | |
| 2023-11-03 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-10-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-16 | CH02 | officers | Change corporate director company with change date | |
| 2023-07-10 | AA | accounts | Accounts with accounts type full | |
| 2022-10-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-07-25 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 6
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
+25.2%
£1,849,932,000 £2,316,344,000
-
Net assets
+1%
£59,741,600,000 £60,341,393,000
-
Employees
—
Not reported
-
Operating profit
+34.5%
£198,480,000 £267,051,000
-
Profit before tax
+57%
£1,698,480,000 £2,667,051,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers